RajVuppalanchiMDFAASLD

[Pronunciation: Vuppa Lanchi]

Hepatology & Liver Transplantation

Professor of Medicine

Dr. Vuppalanchi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
550 University Blvd
Suite 1710
Indianapolis, IN 46202
Phone+1 317-278-1652

Fax+1 317-278-1949

Dr. Raj Vuppalanchi specializes in Gastroenterology with sub-specialties in Hepatology and Liver Transplantation, based in Indianapolis, Indiana. His educational background includes a Gastroenterology fellowship at Indiana University School of Medicine and an Internal Medicine residency at SUNY Health Science Center. He currently holds several positions, including a tenured professorship at Indiana University School of Medicine and a medical staff position at Eskenazi Health. Vuppalanchi’s expertise lies in a variety of liver conditions, including primary biliary cirrhosis, viral hepatitides, and non-alcoholic fatty liver disease. He has multiple publications under his belt and has actively participated in clinical trials for various liver conditions. His commendable work has also brought him several awards, including the Chancellors Teaching Award from Indiana University in 2017.

Indiana University School of MedicineFellowship, Gastroenterology, 2005 - 2007
Indiana Univ Sch Of Medicine Fellowship Clinical Pharmacology, 2003 - 2005
SUNY Downstate Health Sciences University/Long Island College HospitalResidency, Internal Medicine, 2000 - 2003
Gandhi Medical CollegeClass of 1998, MBBS
Little Flower Junior CollegeIntermediate, 1991

Chancellors Teaching Award Indiana University, 2017
GI Attending of the Year Division of Gastroenterology –IUSM, 2009-2010, 2010
Young Clinicians Program American College of Gastroenterology nominee, 2009
Presidential Trainee Award American Society for Clinical Pharmacology and Therapeutics, 2005
Join now to see all

PubMed

A Comprehensive Evaluation of Emergency Department Utilization by Patients With Cirrhosis.
Swetha Parvataneni, Yara Sarkis, Michelle Haugh, Brittany Baker, Qing Tang
The American Journal of Gastroenterology. 2024-12-01
1 citations
PNPLA3 rs738409, environmental factors and liver-related mortality in the US population.
Eduardo Vilar-Gomez, Samer Gawrieh, Raj Vuppalanchi, Carla Kettler, Francis Pike
Journal of Hepatology. 2024-10-09
Pharmacokinetic, Safety, and Pharmacodynamic Profiles of Saroglitazar Magnesium in Cholestatic Cirrhosis With Hepatic Impairment and Participants With Renal Impairment.
Raj Vuppalanchi, Mary M Cruz, Taufik Momin, Farheen Shaikh, Kimberly Swint
Clinical Pharmacology and Therapeutics. 2024-10-02

Journal Articles

Fecal Microbiota Transplantation for the Treatment of Recurrent and Severe Clostridium Difficile Infection in Solid Organ Transplant Recipients: A Multicenter Experience
Raj Vuppalanchi, Adam Ehrlich, Michael Smith, Asif Sharfuddin, Nasia Safdar, Nirmal Kaur, Elizabeth Ann Misch, Monika Fischer, Ann Flynn, Vincent Ganapini, Michael H W..., American journal of transplantation
Liver Stiffness Measurements in Patients with Non‐Cirrhotic Portal Hypertension – the Devil Is in the Details
Niharika Samala, Raj Vuppalanchi, Naga Chalasani, Hepatology
Isolated Melanosis of the Gastric Antrum.
Vuppalanchi R, Vakli S, Kahi C, An Unusual Endoscopic Finding;5(1):e2
Nonalcoholic hepatic steatosis is associated with decreased hepatic CYP3A activity.
Kolwankar D, Vuppalanchi R, Ethell B, Jones D, Wrighton S, Hall S, Chalasani N, Clin Gastroenterol Hepatol; 5(3):388-93
Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network.
Vuppalanchi R, Gould RJ, Wilson LA, Unalp-Arida A, Cummings OW, Chalasani N, Kowdley KV, Hepatol Int
Join now to see all

Books/Book Chapters

Practical Hepatic Pathology: A Diagnostic Approach: A Volume in the Pattern Recognition Series.
Chapter: Metabolism of Drugs and Xenobiotics
Vuppalanchi RElsevierEdition 1st,
Practical Hepatic Pathology: A Diagnostic Approach: A Volume in the Pattern Recognition Series.
Chapter: Laboratory Tests in Liver Disease
Vuppalanchi R, Chalasani NElsevierEdition 1st,

Lectures

Drug-Induced Liver Injury: Causes and Management
AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/6/2018
Liver Transplantation.
St,Vincent Hospital, Indianapolis, IN
Healthy You: Liver lessons.
American Liver Foundation, Indianapolis
Management of NAFLD.
Howard Regional Hospital, Kokomo, IN
NAFLD and NASH.
Indiana Central Association of Diabetes Educators, Indianapolis, IN
Therapies for hepatitis C.
Multiple locations, 2010,2011
Drug induced liver disease.
Reid Hospital, Richmond, IN
Join now to see all

Other

Serum biomarkers for diagnosis of non-alcoholic fatty liver disease.
Vuppalanchi R, US Provisional Patent Application No. 61/273,013

Medical Bulletin 01/ July/ 2024June 30th, 2024
Galectin Therapeutics to Present Clinical Data at the Liver Meeting® 2017 Demonstrating the Ability of Non-Invasive Test to Identify Clinically Significant Portal Hypertension in Patients with Compensated NASH CirrhosisOctober 20th, 2017
miRNA Signatures Can Identify NASH Patients Needing TreatmentJune 5th, 2017